Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Cone-Rod Dystrophy

What is Cone-Rod Dystrophy?

Cone-Rod Dystrophy is an inherited disorder characterized by the loss of cone cells, which are responsible for both central and color vision.


Cone-Rod Dystrophy is an inherited disorder characterized by the loss of cone cells, which are responsible for both central and color vision.
Acknowledgement of Cone-Rod Dystrophy has not been added yet.
Synonyms for Cone-Rod Dystrophy has not been added yet.
The majority of cone-rod dystrophy cases due to mutations in any one of several genes, and CRDs can be inherited as autosomal recessive, autosomal dominant, X-linked or mitochondrial (maternally-inherited) traits. CRDs are usually non-syndromic, but they may also be part of several syndromes (
Initial signs and symptoms typically include decreased visual acuity when looking straight ahead (central vision loss) and loss of color perception; and an abnormal sensitivity to light (photophobia). These signs are usually followed by progressive loss of peripheral vision and night blindness. This is followed by a wide-range of possible symptoms: abnormalities in the eyes/ears, intellectual disability, blindness, retinal flecks and central scotoma (
Clinical diagnosis is based on the early decrease of visual acuity and photophobia, lesions in fundus, hypovolted ERG traces with predominant cone involvement, and progressive worsening of these signs. Full field ERG is the key test. At present, a systematic molecular testing is not routinely performed, due to the tremendous genetic heterogeneity of the disease. However, rapid and large-scale mutation screening techniques are developing and several laboratories perform search for mutations in the most frequently involved genes, includingABCA4, CRX, GUC1A; strategies to test in a short time several dozen of genes for a single patient DNA are emerging. Differential diagnoses are: Retinitis pigmentosa, Leber congenital amaurosis (LCA), Maculopathies ans Stationary retinal diseases (
Diagnostic tests of Cone-Rod Dystrophy has not been added yet
There are currently no specific therapies or treatments that can stop the progression of cone-rod dystrophy or restore vision, however there are ways to manage the disease. Light avoidance and low-vision aids may help to slow down the degenerative process ( The beta-carotenoids, lutein and zeaxanthin, have been evidenced to reduce the risk of developing age related macular degeneration (AMD). Consuming omega-3 fatty acids (docosahexaenoic acid and eicosapentaenoic acid) has been correlated with a reduced progression of early AMD, and in conjunction with low glycemic index foods, with reduced progression of advanced AMD ( Finally, it is also important for patients to receive support to help them cope with the social and psychological impact of vision loss (
Prognosis of Cone-Rod Dystrophy has not been added yet.
Tips or Suggestions of Cone-Rod Dystrophy has not been added yet.
References of Cone-Rod Dystrophy has not been added yet.
Living with Created by Kimjar
Last updated 26 Feb 2014, 09:30 PM

Posted by Kimjar
26 Feb 2014, 09:30 PM

I am a mother of an 18 year old who has been diagnosed with Cone there anyone who has come up with some way of dealing with the day to days...special glasses or something?

Community Resources
Title Description Date Link

Clinical Trials

Cords registry

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.

Enrolling is easy.

  1. Complete the screening form.
  2. Review the informed consent.
  3. Answer the permission and data sharing questions.

After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.

Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.

Visit to enroll.

Community Leaders


Expert Questions

Ask a question

Community User List

My daughter is 9 had cone and rod dystrophy. Diagnosed 1 1/2 years ago. Sees 20/400.
1.My Name Is Siraj


2. I am 12 years Old


3. I was diagnosed with cone-rod dystrophy June 2010


4. I live in Gibraltar


5. I goto to Bayside Secondary School



I am 55 years old. I was diagnozed in 2002 and am now legally blind (in Jan. 21008).



I worked as an Accountant my whole life until I was declared legally blind.



I have a...

Start a Community

Don't See Your Condition On Rareshare?

Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.


Have questions about rareshare?

Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.

Discussion Forum

Living with

Created by Kimjar | Last updated 26 Feb 2014, 09:30 PM


Our Communities

Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.


Our Resources

Our rare disease resources include e-books and podcasts





Our Community Leaders

Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.